Smith-Farrell Joanne

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(4%)8%7%0%0%
Sale Success Rate6 of 105 of 102 of 100 of 100 of 10
Drugs » Biotechnology

COO, Oncology:

Holdings: 20.61K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Diagnostic Substances

VP Corp Development & Strategy:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--